Abstract
Antiretroviral therapy (ART) offers a powerful intervention in HIV but effectiveness can be compromised by inadequate adherence. This paper is a detailed examination of the experience of medication in a purposively selected group of people living with HIV. In-depth interviews were conducted with 10 HIV positive, West African women of black heritage living in London, UK. This group was of interest since it is the second largest group affected by HIV in the UK. Interviews were subjected to interpretative phenomenological analysis, an idiographic, experiential, qualitative approach. The paper details the women’s negative experience of treatment. ART can be considered difficult and unrelenting and may be disconnected from the women’s sense of health or illness. Participants’ social context often exacerbated the difficulties. Some reported an improvement in their feelings about the medication over time. These findings point to some intrinsic and social motivators which could act as spurs to adherence.
Similar content being viewed by others
Notes
[…] indicates editorial elision.
References
Bulteel N, Bansi-Matharu L, Churchill D, Dunn D, Bibby D, Hill T, et al. The emergence of drug resistant HIV variants at virological failure of HAART combinations containing efavirenz, tenofovir and lamivudine or emtricitabine within the UK Collaborative HIV Cohort. J Infect. 2014;68(1):77–84.
Cohen M, Chen Y, McCauley M, Gamble T, Hosseinipour M, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.
MacDonell K, Naar-King S, Murphy D, Parsons J, Harper G. Predictors of medication adherence in high risk youth of color living with HIV. J Pediatr Psychol. 2010;35(6):593–601.
Fogarty L, Roter D, Larson S, Burke J, Gillespie J, Levy R. Patient adherence to HIV medication regimens: a review of published and abstract reports. Patient Educ Couns. 2002;46:93–108.
Horne R, Cooper V, Gellaitry G, Leake Date H, Fisher M. Patients’ perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence. Epidemiol Soci Sci. 2007;45(3):334–41.
Hill S, Kavookjian J. Motivational interviewing as behavioural intervention to increase HAART adherence in patients who are HIV-positive: a systematic review of the literature. AIDS Care. 2012;24(5):583–92.
England PH. Sexual and reproductive health in England: A guide to local and national data. 2015.
Watt M, Maman S, Earp J, Eng E, Setel P, Golin C, et al. It’s all the time in my mind: facilitators of adherence to antiretroviral therapy in a Tanzanian setting. Soc Sci Med. 2009;68(10):1793–800.
Williams I, Churchill D, Anderson J, Boffito M, Bower M, Cairns G, et al. British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012. HIV Med. 2014;15(S1):1–6.
Adewuya A, Afolabi M, Ola B, Ogundele O, Ajibare A, Oladipo B, et al. The effect of psychological distress on medication adherence in persons with HIV infection in Nigeria. Psychosomatics. 2010;51(1):68–73.
Doyal L, Anderson J. My fear is to fall in love again… How HIV-positive African women survive in London. Soc Sci Med. 2004;60:1729–38.
Flowers P, Davis M, Hart G, Rosengarten M, Frankis J, Imrie J. Diagnosis and stigma and identity amongst HIV positive Black Africans living in the UK. Psychol Health. 2006;21(1):109–22.
Doyal L, Anderson J, Paparini S. ‘You are not yourself’: exploring masculinities among heterosexual African men living with HIV in London. Soc Sci Med. 2009;68(10):1901–7.
Burns F, Imrie J, Nazroo J, Johnson A, Fenton K. Why the (y) wait? Key informant understandings of factors contributing to late presentation and poor utilization of HIV health and social care services by African migrants in Britain. AIDS Care. 2007;19(1):102–8.
Stutterheim S, Bos A, Shiripinda I, de Bruin M, Pryor J, Schaalma H. HIV-related stigma in African and Afro-Caribbean communities in the Netherlands: manifestations, consequences and coping. Psychol Health. 2012;27(4):395–411.
Vervoot S, Borleffs J, Hoepelman A, Grypdonck M. Adherence in antiretroviral therapy: a review of qualitative studies. AIDS. 2007;21:271–81.
Sankar A, Luborsky M, Schuman P, Roberts G. Adherence discourse among African-American women taking HAART. AIDS Care. 2002;14(2):203–18.
Chaiyachati K, Ogbuoji O, Price M, Suthar A, Negussie E, Barnighausen T. Interventions to improve adherence to antiretroviral therapy: a rapid systematic review. AIDS. 2014;28(S2):187–204.
Smith J, Flowers P, Larkin M. Interpretative phenomenological analysis: theory, method and research. London: Sage; 2009.
Skinta M, Brandrett B, Schenk W, Wells G, Dilley J. Shame, self-acceptance and disclosure in the lives of gay men living with HIV: an interpretative phenomenological analysis approach. Psychol Health. 2014;29(5):583–97.
Brocki J, Wearden A. A critical evaluation of the use of interpretative phenomenological analysis (IPA) in health psychology. Psychology and Health. 2005;21(1):87–108.
Glaser B, Strauss A. The discovery of grounded theory: strategies for qualitative research. New York: Aldine; 1967.
Glaser B. Emergence vs forcing: basics of grounded theory analysis. Mill Valley: Sociology Press; 1992.
Crossley M. Narrative Analysis. In: Lyons E, Coyle A, editors. Analysing qualitative data in psychology. London: Sage; 2007.
Giorgi A. Description versus interpretation: competing alternative strategies for qualitative research. J Phenomenol Psychol. 1992;23(2):119–35.
Sandelowski M. One is the liveliest number: the case orientation of qualitative research. Res Nurs Health. 1996;19:525–9.
Malcolm S, Ng J, Rosen R, Stone V. An examination of HIV/AIDS patients who have excellent adherence to HAART. AIDS Care. 2003;15(2):251–61.
Remien R, Hirky A, Johnson M, Weinhardt L, Whittier D, Le G. Adherence to medication treatment: a qualitative study of facilitators and barriers among a diverse sample of HIV+ men and women in four US cities. AIDS Behav. 2003;7(1):61–72.
Erwin J, Peters B. Treatment issues for HIV+ Africans living in London. Soc Sci Med. 1999;49(11):1519–28.
Penn C, Watermeyer J, Evans M. Why don’t patients take their drugs? The role of communication, context and culture in patient adherence and the work of the pharmacist in HIV/AIDS. Patient Educ Couns. 2011;83(3):310–8.
Joglekar N, Paranjape R, Jain R, Rahane G, Potdar R, Reddy K, et al. Barriers to ART adherence & follow ups among patients attending ART centres in Maharashtra, India. Indian J Med Res. 2011;134(6):954.
Gonzalez J, Penedo F, Llabre M, Durán R, Antoni M, Schneiderman N, et al. Physical symptoms, beliefs about medications, negative mood, and long-term HIV medication adherence. Ann Behav Med. 2007;34(1):46–55.
Kawuma R, Bernays S, Siu G, Rhodes T, Seeley J. Children will always be children’: exploring perceptions and experiences of HIV-positive children who may not take their treatment and why they may not tell. African J AIDS Res. 2014;13(2):189–95.
Boehme A, Davies S, Moneyham L, Shrestha S, Schumacher J, Kempf M. A qualitative study on factors impacting HIV care adherence among postpartum HIV-infected women in the rural southeastern USA. AIDS Care. 2014;26(5):574–81.
Di Matteo M. Variations in patients adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42(3):200–9.
Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med. 2007;4(10):e298.
Acknowledgments
This research was funded by the National Institute for Health Research (NIHR) in the UK.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Spiers, J., Smith, J.A., Poliquin, E. et al. The Experience of Antiretroviral Treatment for Black West African Women who are HIV Positive and Living in London: An Interpretative Phenomenological Analysis. AIDS Behav 20, 2151–2163 (2016). https://doi.org/10.1007/s10461-015-1274-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10461-015-1274-9